ECIA Encision Inc. featured news, full reports, and detailed charts
Encision Inc. (ECIA/ECIA.OB) Wrap Up:
Encision, Inc., a medical device company, engages in the design, development, manufacture, and marketing of surgical instruments that provide safety to patients undergoing minimally-invasive surgery. It offers a line of AEM surgical instruments, which prevents stray electrosurgical burns from insulation failure and capacitive coupling. The company’s product line includes a range of articulating instruments, such as scissors, graspers, and dissectors; fixed-tip electrodes; and suction-irrigation electrodes. In addition, it markets the AEM Monitor product line that is used in conjunction with the AEM Instruments. Encision sells its products primarily to hospitals through a distribution network...www.encision.com
54 Employees
Founded in 1991
Encision Inc. (ECIA:OTC Bulletin Board Market)
LAST $1.50 USD
CHANGE TODAY 0.00 0.00%
VOLUME 0.0
As of November 19, 2009 All times are local (Market data by Reuters is delayed by at least 15 minutes).
Snapshot of Encision Inc. (ECIA)
|
OPEN
--
|
PREVIOUS CLOSE
$1.50
|
|
|
DAY HIGH
--
|
DAY LOW
--
|
|
|
52 WEEK HIGH
05/20/09 - $2.00
|
52 WEEK LOW
03/18/09 - $0.30
|
|
|
MARKET CAP
9.7M
|
AVERAGE VOLUME 3 mo
2.7K
|
|
|
DILUTED EPS TTM
$0.07
|
SHARES OUTSTANDING
6.5M
|
|
|
ECIA Does Not Pay Dividends
|
P/E TTM
20.4x
|
|
| K = Thousands M = Millions B = Billions | ||
ECIA Top Compensated Officers
Mr. John R. Serino
Chief Executive Officer, President and Direct...
Age: 61
Total Annual Compensation: $202.7K
Mr. Roger C. Odell
Co-Founder, Chairman of the Board and Vice Pr...
Age: 58
Total Annual Compensation: $140.4K
Mr. David W. Newton
Co-Founder, Vice President of Technology and ...
Age: 62
Total Annual Compensation: $117.4K
Mr. Warren Taylor
Vice President of Engineering
Age: 48
Total Annual Compensation: $139.0K
Executives, Board Directors
Compensation as of Fiscal Year 2009.
Key developments for Encision Inc. (ECIA)
Encision Inc. Announces Unaudited Consolidated Financial Results for the Second Quarter and Six Months Ended September 30, 2009
10/29/2009
Encision Inc. announced unaudited consolidated financial results for the second quarter and six months ended September 30, 2009. For the quarter, the company reported net sales of $3,216,000, operating income of $62,000, income before provision for income tax of $46,000, net income of $46,000 or $0.01 per diluted share against net sales of $3,346,000, operating income of $92,000, income before provision for income tax of $75,000, net income of $75,000 or $0.01 per diluted share a year ago. For the six months, the company reported net sales of $6,389,000, operating income of $240,000, income before provision for income tax of $210,000, net income of $210,000 or $0.03 per diluted share against net sales of $6,440,000, operating loss of $73,000, loss before provision for income tax of $89,000, net loss of $89,000 or $0.01 loss per diluted share a year ago.
Encision Inc. Announces Unaudited Earnings Results for the First Quarter Ended June 30, 2009
07/30/2009
Encision Inc. announced unaudited earnings results for the first quarter ended June 30, 2009. Net sales for the three-months ended June 30, 2009 totaled $3.2 million, representing a 3% increase over net sales of $3.1 million for the prior fiscal year's first quarter. The company recorded net income of $163,000 or $0.03 per share and operating income of $178,000 for the first quarter of fiscal year 2010, compared to a net loss of $164,000 or $0.03 per share and operating loss of $165,000 for the first quarter of fiscal year 2009. Net income increased from last year's first quarter net loss as a result of a slight increase in sales income, increased gross profit margin and reduced operating expenses. Income before provision for income taxes was $163,000 against loss before provision for income taxes of $164,000 for the same period a year ago.
Encision Inc., Annual General Meeting, Aug 05, 2009
06/29/2009
Encision Inc., Annual General Meeting, Aug 05, 2009, at 10:00 Mountain Daylight. Location: Faegre & Benson LLP, 1900 Fifteenth Street, Boulder Co. 80302, United States. Agenda: To elect seven directors; to ratify the appointment of Eide Bailly LLP as independent public accountants; and to transact such other business as may properly come before the meeting, or any adjournment thereof.
ECIA Competitors
| Company | Last | Change | |
| No competitor information is available for ECIA. | |||
| Market data is delayed at least 20 minutes. | |||
Industry Analysis
| Valuation | ECIA | Industry Range |
| Price/Earnings | 21.1x |
|
| Price/Sales | 0.8x |
|
| Price/Book | 2.8x |
|
| Price/Cash Flow | 21.1x |
|
| TEV/Sales | 0.7x |
|
|
ECIA |
||
|
ECIA transactions
| Type Date |
Target | |
| No transactions in the last 6 months. | ||
More Recent News About Encision Inc.
More news for ECIA
ENCISION INC Files SEC form 10-Q, Quarterly Report
ITEM 2 † MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS Certain statements contained in this section on Management's Discussion and Analysis are not historical facts, including statements about our strategies and expectations with respect to new and existing products, market demand, acceptance of new and existing products, marketing efforts, technologies and opportunities, market and industry segment growth, and return on investments in products and markets. These statements are forward looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and involve substantial risks and uncertainties that may cause actual results to differ materially from those indicated by the forward looking statements. All forward looking statements in this section on Management's Discussion and Analysis are based on information available to us on the date of this document, and we assume no obligation to update such forward looking statements. Readers of this Form 10-Q are strongly encouraged to review the section entitled "Risk Factors" in our Form 10-K for the fiscal year ended March 31, 2009. General Encision Inc., a medical device company based in Boulder, Colorado, has developed and launched innovative technology that is emerging as a standard of care in minimally-invasive surgery. We believe that our patented AEM® Surgical Instruments are changing the marketplace for electrosurgical devices and laparoscopic instruments by providing a solution to a well documented patient safety risk in laparoscopic surgery. We were founded to address market opportunities created by the increase in minimally-invasive surgery ("MIS") and surgeons' preference for using electrosurgery devices in these procedures. The product opportunity was created by surgeons' continued widespread demand for using monopolar electrosurgery instruments, which, when used in laparoscopic surgery, are susceptible to causi...Click here to read the whole Article (external link)
ENCISION INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
Show all filings for ENCISION INC | Request a Trial to NEW EDGAR Online Pro Form 8-K for ENCISION INC 12-Nov-2009Regulation FD Disclosure, Financial Statements and Exhibits Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service - Copyright/IP Policy - Send Feedback SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational pur...Click here to read the whole Article (external link)
ENCISION INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Show all filings for ENCISION INC | Request a Trial to NEW EDGAR Online Pro Form 8-K for ENCISION INC 10-Nov-2009Entry into a Material Definitive Agreement, Financial Statements and Exhibits Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service - Copyright/IP Policy - Send Feedback SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" fo...Click here to read the whole Article (external link)
ENCISION INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
Show all filings for ENCISION INC | Request a Trial to NEW EDGAR Online Pro Form 8-K for ENCISION INC 30-Oct-2009Results of Operations and Financial Condition, Financial Statements and Exhibits Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service - Copyright/IP Policy - Send Feedback SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is"...Click here to read the whole Article (external link)
Encision Reports Profitable Second Fiscal Quarter Results
BOULDER, Colo., Oct. 29 /PRNewswire-FirstCall/ -- Encision Inc. (OTC Bulletin Board: ECIA - News), a medical device company owning patented surgical technology that is emerging as a standard of care in minimally-invasive surgery, reported its financial results for its second quarter of fiscal year 2010. Net sales for the three months ended September 30, 2009 totaled $3.22 million, representing a 4% decrease over net sales of $3.35 million for the prior fiscal year's second quarter. The Company recorded net income of $46 thousand, or $.01 per share, for the second quarter of fiscal year 2010, compared to a net income of $75 thousand, or $.01 per share, for the second quarter of fiscal year 2009. Gross profit margin for the second quarter of fiscal year 2010 was 60.5%, as compared to 61.3% for the second quarter of fiscal year 2009. The higher gross profit margin for the second quarter of fiscal year 2009 was due to a reduction of warranty accrual which increased the gross profit margin by 0.7%.Net sales for the first six months ended September 30, 2009 totaled $6.39 million, representing a 1% decrease over net sales of $6.44 million for the prior fiscal year's first six months. The Company recorded net income of $210 thousand, or $.03 per share, for the first six months of fiscal year 2010, compared to a net loss of $89 thousand, or ($.01) per share, for the first six months of fiscal year 2009. Gross profit margin for the first six months of fiscal year 2010 was 62.2%, as compared to 60.8% for the first six months of fi...Click here to read the whole Article (external link)
ENCISION INC Financials
PERIOD ENDING30-Jun-0931-Mar-0931-Dec-0830-Sep-08Total Revenue3,174 3,078 3,271 3,346 Cost of Revenue1,142 1,108 1,191 1,294 Gross Profit2,032 1,970 2,079 2,052 Operating ExpensesResearch Development301 283 287 280 Selling General and Administrative1,553 1,654 1,546 1,680 Non Recurring - - - - Others - - - - Total Operating Expenses - - - - Operating Income or Loss178 34 247 92 Income from Continuing OperationsTotal Other Income/Expenses Net(2)(5)1 0 Earnings Before Interest And Taxes176 28 247 92 Interest Expense13 13 14 17 Income Before Tax163 16 233 75 Income Tax Expense - - - - Minority Interest - - - - Net Income From Continuing Ops163 16 233 75 Non-recurring EventsDiscontinued Operations - - - - Extraordinary Items - - - - Effect Of Accounting Changes - ...Click here to read the whole Article (external link)
ENCISION INC Files SEC form 10-Q, Quarterly Report
ITEM 2 † MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS Certain statements contained in this section on Management's Discussion and Analysis are not historical facts, including statements about our strategies and expectations with respect to new and existing products, market demand, acceptance of new and existing products, marketing efforts, technologies and opportunities, market and industry segment growth, and return on investments in products and markets. These statements are forward looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and involve substantial risks and uncertainties that may cause actual results to differ materially from those indicated by the forward looking statements. All forward looking statements in this section on Management's Discussion and Analysis are based on information available to us on the date of this document, and we assume no obligation to update such forward looking statements. Readers of this Form 10-Q are strongly encouraged to review the section entitled "Risk Factors" in our Form 10-K for the fiscal year ended March 31, 2009. General Encision Inc., a medical device company based in Boulder, Colorado, has developed and launched innovative technology that is emerging as a standard of care in minimally-invasive surgery. We believe that our patented AEM® Surgical Instruments are changing the marketplace for electrosurgical devices and laparoscopic instruments by providing a solution to a well documented patient safety risk in laparoscopic surgery. We were founded to address market opportunities created by the increase in minimally-invasive surgery ("MIS") and surgeons' preference for using electrosurgery devices in these procedures. The product opportunity was created by surgeons' continued widespread demand for using monopolar electrosurgery instruments, which, when used in laparoscopic surgery, are susceptible to causi...Click here to read the whole Article (external link)
ENCISION INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
Show all filings for ENCISION INC | Request a Trial to NEW EDGAR Online Pro Form 8-K for ENCISION INC 3-Aug-2009Results of Operations and Financial Condition, Financial Statements and Exhibits Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service - Copyright/IP Policy - Send Feedback SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" ...Click here to read the whole Article (external link)
ENCISION INC Files SEC form 10-K, Annual Report
Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations. Certain statements contained in this section are not historical facts, including statements about our strategies and expectations about new and existing products, market demand, acceptance of new and existing products, technologies and opportunities, market and industry segment growth, and return on investments in products and markets. These statements are forward looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and involve substantial risks and uncertainties that may cause actual results to differ materially from those indicated by the forward looking statements. All forward looking statements in this section are based on information available to us on the date of this document, and we assume no obligation to update such forward looking statements. Readers of this Form 10-K are strongly encouraged to review the section entitled "Risk Factors". Outlook Installed Base of AEM Monitoring Equipment. We believe that sales of our installed base of our AEM monitors will increase as the inherent risks associated with monopolar laparoscopic electrosurgery become more widely acknowledged and as the network of direct and independent sales representatives becomes more adept at selling AEM products to our customers. We expect that the replacement sales of electrosurgical instruments and accessories will also increase as additional hospitals are converted to AEM technology. We believe that improvement in the quality of sales representatives carrying AEM product line, along with increased marketing efforts and the introduction of new products, may provide the basis for increased sales and continuing profitable operations. However, these measures, or any others that we may adopt, may not result in either increased sales or continuing profitable operations. Possibility of Continued Operating Losses. We have, except for the fisc...Click here to read the whole Article (external link)
ENCISION INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
Show all filings for ENCISION INC | Request a Trial to NEW EDGAR Online Pro Form 8-K for ENCISION INC 20-May-2009Results of Operations and Financial Condition, Financial Statements and Exhibits Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service - Copyright/IP Policy - Send Feedback SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" ...Click here to read the whole Article (external link)
Would you like to leave a comment about Encision Inc. ECIA/ECIA.OB
Find out what social network information about Encision Inc. are available on RealpenniesWorst 5 - Click here to find out what stocks have been voted down by our visitors and users
Besides Encision Inc. there is more great information available at Realpennies.com